Clarity Pharmaceuticals Statistics

Total Valuation

ASX:CU6 has a market cap or net worth of AUD 1.26 billion. The enterprise value is 1.03 billion.

Market Cap	1.26B
Enterprise Value	1.03B

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:CU6 has 372.03 million shares outstanding. The number of shares has increased by 13.88% in one year.

Current Share Class	372.03M
Shares Outstanding	372.03M
Shares Change (YoY)	+13.88%
Shares Change (QoQ)	+13.25%
Owned by Insiders (%)	13.15%
Owned by Institutions (%)	24.86%
Float	264.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	119.21
PB Ratio	5.42
P/TBV Ratio	5.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.74
EV / Sales	97.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.26

Financial Position

The company has a current ratio of 11.43

Current Ratio	11.43
Quick Ratio	10.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.45% and return on invested capital (ROIC) is -33.30%.

Return on Equity (ROE)	-53.45%
Return on Assets (ROA)	-30.54%
Return on Invested Capital (ROIC)	-33.30%
Return on Capital Employed (ROCE)	-41.12%
Weighted Average Cost of Capital (WACC)	11.09%
Revenue Per Employee	153,331
Profits Per Employee	-1.40M
Employee Count	69
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:CU6 has paid 722,863 in taxes.

Income Tax	722,863
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.78% in the last 52 weeks. The beta is 1.24, so ASX:CU6's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-4.78%
50-Day Moving Average	3.38
200-Day Moving Average	3.49
Relative Strength Index (RSI)	49.69
Average Volume (20 Days)	2,347,587

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CU6 had revenue of AUD 10.58 million and -96.35 million in losses. Loss per share was -0.28.

Revenue	10.58M
Gross Profit	10.58M
Operating Income	-95.96M
Pretax Income	-95.52M
Net Income	-96.35M
EBITDA	-95.71M
EBIT	-95.96M
Loss Per Share	-0.28

Full Income Statement

Balance Sheet

The company has 226.25 million in cash and n/a in debt, giving a net cash position of 226.25 million or 0.61 per share.

Cash & Cash Equivalents	226.25M
Total Debt	n/a
Net Cash	226.25M
Net Cash Per Share	0.61
Equity (Book Value)	232.81M
Book Value Per Share	0.63
Working Capital	232.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -72.26 million and capital expenditures -336,728, giving a free cash flow of -72.59 million.

Operating Cash Flow	-72.26M
Capital Expenditures	-336,728
Free Cash Flow	-72.59M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-906.99%
Pretax Margin	-902.89%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:CU6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.88%
Shareholder Yield	-13.88%
Earnings Yield	-7.64%
FCF Yield	-5.76%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:CU6 has an Altman Z-Score of 28.72 and a Piotroski F-Score of 2.

Altman Z-Score	28.72
Piotroski F-Score	2